194 related articles for article (PubMed ID: 27779649)
1. Effect of curcumin and paclitaxel on breast carcinogenesis.
Quispe-Soto ET; Calaf GM
Int J Oncol; 2016 Dec; 49(6):2569-2577. PubMed ID: 27779649
[TBL] [Abstract][Full Text] [Related]
2. Curcumin and paclitaxel induce cell death in breast cancer cell lines.
Calaf GM; Ponce-Cusi R; Carrión F
Oncol Rep; 2018 Oct; 40(4):2381-2388. PubMed ID: 30066930
[TBL] [Abstract][Full Text] [Related]
3. Apoptotic activity of 5-fluorouracil in breast cancer cells transformed by low doses of ionizing α-particle radiation.
Ponce-Cusi R; Calaf GM
Int J Oncol; 2016 Feb; 48(2):774-82. PubMed ID: 26691280
[TBL] [Abstract][Full Text] [Related]
4. Curcumin enhances the anticancer effects of trichostatin a in breast cancer cells.
Yan G; Graham K; Lanza-Jacoby S
Mol Carcinog; 2013 May; 52(5):404-11. PubMed ID: 22290509
[TBL] [Abstract][Full Text] [Related]
5. Small inhibitor of Bcl-2, HA14-1, selectively enhanced the apoptotic effect of cisplatin by modulating Bcl-2 family members in MDA-MB-231 breast cancer cells.
Arisan ED; Kutuk O; Tezil T; Bodur C; Telci D; Basaga H
Breast Cancer Res Treat; 2010 Jan; 119(2):271-81. PubMed ID: 19238538
[TBL] [Abstract][Full Text] [Related]
6. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice.
Aggarwal BB; Shishodia S; Takada Y; Banerjee S; Newman RA; Bueso-Ramos CE; Price JE
Clin Cancer Res; 2005 Oct; 11(20):7490-8. PubMed ID: 16243823
[TBL] [Abstract][Full Text] [Related]
7. Curcumin reverses chemoresistance of human gastric cancer cells by downregulating the NF-κB transcription factor.
Yu LL; Wu JG; Dai N; Yu HG; Si JM
Oncol Rep; 2011 Nov; 26(5):1197-203. PubMed ID: 21811763
[TBL] [Abstract][Full Text] [Related]
8. Curcumin inhibits proliferation and migration by increasing the Bax to Bcl-2 ratio and decreasing NF-kappaBp65 expression in breast cancer MDA-MB-231 cells.
Chiu TL; Su CC
Int J Mol Med; 2009 Apr; 23(4):469-75. PubMed ID: 19288022
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of sensitive assays to quantitate gene expression after p53 gene therapy and paclitaxel chemotherapy using in vivo dosing in tumor xenograft models.
Wen SF; Xie L; McDonald M; DiGiacomo R; Chang A; Gurnani M; Shi B; Liu S; Indelicato SR; Hutchins B; Nielsen LL
Cancer Gene Ther; 2000 Nov; 7(11):1469-80. PubMed ID: 11129289
[TBL] [Abstract][Full Text] [Related]
10. Apoptotic effect of noscapine in breast cancer cell lines.
Quisbert-Valenzuela EO; Calaf GM
Int J Oncol; 2016 Jun; 48(6):2666-74. PubMed ID: 27081867
[TBL] [Abstract][Full Text] [Related]
11. Differential effect of anti-apoptotic genes Bcl-xL and c-FLIP on sensitivity of MCF-7 breast cancer cells to paclitaxel and docetaxel.
Wang Z; Goulet R; Stanton KJ; Sadaria M; Nakshatri H
Anticancer Res; 2005; 25(3c):2367-79. PubMed ID: 16080463
[TBL] [Abstract][Full Text] [Related]
12. Curcumin Suppresses M2 Macrophage-derived Paclitaxel Chemoresistance through Inhibition of PI3K-AKT/STAT3 Signaling.
Deswal B; Bagchi U; Kapoor S
Anticancer Agents Med Chem; 2024; 24(2):146-156. PubMed ID: 37957871
[TBL] [Abstract][Full Text] [Related]
13. CKD712, a synthetic isoquinoline alkaloid, enhances the anti-cancer effects of paclitaxel in MDA-MB-231 cells through regulation of PTEN.
Kim YM; Tsoyi K; Jang HJ; Park EJ; Park SW; Kim HJ; Hwa JS; Chang KC
Life Sci; 2014 Sep; 112(1-2):49-58. PubMed ID: 25058922
[TBL] [Abstract][Full Text] [Related]
14. Rationale for sequential tamoxifen and anticancer drugs in adjuvant setting for patients with node- and receptor-positive breast cancer.
Kim R; Tanabe K; Emi M; Uchida Y; Osaki A; Toge T
Int J Oncol; 2005 Apr; 26(4):1025-31. PubMed ID: 15753998
[TBL] [Abstract][Full Text] [Related]
15. Induction of apoptosis by diphenyldifluoroketone in osteogenic sarcoma cells is associated with activation of caspases.
Yang SJ; Lee SA; Park MG; Kim JS; Yu SK; Kim CS; Kim JS; Kim SG; Oh JS; Kim HJ; Chun HS; Kim YH; Kim DK
Oncol Rep; 2014 May; 31(5):2286-92. PubMed ID: 24604218
[TBL] [Abstract][Full Text] [Related]
16. Profilin potentiates chemotherapeutic agents mediated cell death via suppression of NF-κB and upregulation of p53.
Zaidi AH; Raviprakash N; Mokhamatam RB; Gupta P; Manna SK
Apoptosis; 2016 Apr; 21(4):502-13. PubMed ID: 26842845
[TBL] [Abstract][Full Text] [Related]
17. Activation of the mitochondria-driven pathway of apoptosis in human PC-3 prostate cancer cells by a novel hydrophilic paclitaxel derivative, 7-xylosyl-10-deacetylpaclitaxel.
Jiang S; Zu Y; Fu Y; Zhang Y; Efferth T
Int J Oncol; 2008 Jul; 33(1):103-11. PubMed ID: 18575755
[TBL] [Abstract][Full Text] [Related]
18. Gallic acid potentiates the apoptotic effect of paclitaxel and carboplatin via overexpression of Bax and P53 on the MCF-7 human breast cancer cell line.
Aborehab NM; Elnagar MR; Waly NE
J Biochem Mol Toxicol; 2021 Feb; 35(2):e22638. PubMed ID: 33002289
[TBL] [Abstract][Full Text] [Related]
19. The antitumor activities of curcumin and of its isoxazole analogue are not affected by multiple gene expression changes in an MDR model of the MCF-7 breast cancer cell line: analysis of the possible molecular basis.
Poma P; Notarbartolo M; Labbozzetta M; Maurici A; Carina V; Alaimo A; Rizzi M; Simoni D; D'Alessandro N
Int J Mol Med; 2007 Sep; 20(3):329-35. PubMed ID: 17671737
[TBL] [Abstract][Full Text] [Related]
20. Id-1 regulates Bcl-2 and Bax expression through p53 and NF-kappaB in MCF-7 breast cancer cells.
Kim H; Chung H; Kim HJ; Lee JY; Oh MY; Kim Y; Kong G
Breast Cancer Res Treat; 2008 Nov; 112(2):287-96. PubMed ID: 18158619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
